Nature Reviews Cancer Acceptance Rate

There is no open-submission acceptance-rate figure here that authors should treat as a reliable planning signal.

What is stable is the submission model:

• Nature Reviews Cancer is a commissioned review journal
• the editorial team selects topics and authors directly
• the real filter happens before a manuscript is drafted
• final peer review still matters, but the biggest selectivity is upstream

That is the planning surface authors should actually use.

Nature Reviews Cancer is usually deciding:

• whether a topic needs a major authoritative synthesis now
• whether the authors are visible and trusted enough to carry that synthesis
• whether the article will organize the field rather than summarize it passively
• whether the piece will speak to a broad cancer-research audience

Those are the questions that matter more than a rumored percentage.

For Nature Reviews Cancer, the useful question is:

Would the editors see this topic and author team as right for a commissioned field-shaping cancer review?

If yes, the journal is relevant. If no, the acceptance-rate discussion is mostly noise.

The common misses are:

• centering strategy around an unofficial percentage
• treating the journal like an elite but ordinary review venue
• cold-writing a full manuscript before any editorial relationship exists
• using impact-factor prestige as a substitute for real commission fit

Those are fit problems before they are rate problems.

If you are deciding whether to pursue this lane, these pages are more useful than an unofficial rate:

• how to choose a journal for your paper
• is my paper ready for Nature Reviews Molecular Cell Biology
• Chemical Reviews acceptance rate
• Nature Reviews Cancer journal page

Together, they tell you whether the article belongs in a commissioned review model at all and whether another review venue would be more realistic.

The honest answer to "what is the Nature Reviews Cancer acceptance rate?" is that there is no strong official number you should treat as exact.

The useful answer is:

• yes, the journal is extremely selective
• no, a guessed percentage is not the right planning tool
• use commissioning reality, topic scope, and author authority instead

If you want help deciding whether this project belongs in a commissioned review lane or should be reframed for a different journal model, a Nature Reviews Cancer submission readiness check is the best next step.

In our pre-submission review work evaluating manuscripts targeting Nature Reviews Cancer, three patterns generate the most consistent editorial returns. Each reflects the journal's standard: commissioned, field-organizing synthesis on cancer topics of broad significance, written by authors with established standing in the cancer research community.

Unsolicited manuscript submitted without prior editorial contact. Nature Reviews Cancer operates as a commissioned review journal, meaning the editorial team identifies topics and authors rather than receiving open submissions in the way a primary-research journal does. The failure pattern is a complete or near-complete review manuscript submitted cold, without any presubmission inquiry, without any prior communication establishing editorial interest, and without an invitation from the journal. Authors sometimes submit unsolicited because the journal's aims describe the scope broadly and do not explicitly state that it is primarily commissioned. The practical effect is that unsolicited manuscripts compete against topics the editors have already identified as priorities, are evaluated without the context of an editorial relationship, and are often returned without detailed feedback because the topic may simply not be on the editorial agenda for the current period. The correct entry point is a presubmission inquiry or proposal sent to the editorial office before substantial writing has begun.

Narrow tumor-type or pathway-specific review without cross-cancer synthesis value. The second pattern is a rigorous, well-written review that is too narrow in scope to justify publication in a flagship cross-cancer journal. Nature Reviews Cancer is designed for reviews that organize how the cancer research community thinks about a broad topic: DNA damage response across cancer types, tumor immunology mechanisms relevant to multiple treatment modalities, metabolic reprogramming as a general cancer biology principle. The failure pattern is a review focused on one specific tumor type's molecular landscape, one resistance mechanism in one treatment context, or one signaling pathway's role in a narrow cancer biology question. These reviews are appropriate for journals like Cancer Letters, Oncogene, or tumor-specific society journals that serve a narrower readership aligned with the topic. Editors at Nature Reviews Cancer evaluate whether the review would be read by cancer researchers across multiple tumor types and research areas, not just the specialists working on the specific topic.

Primary research manuscript reframed as a review. The third pattern is an original research paper that has been reformatted with a longer introduction and an expanded discussion to give it the appearance of a review article, submitted to Nature Reviews Cancer either because the research findings are too preliminary for a primary research journal at this tier or because the authors hope the review format will make the work acceptable at a higher-IF venue. Editors identify these submissions because the literature coverage is thin relative to a genuine synthesis, the experimental data sections remain the primary content, and the "review" of existing literature reads more like an extended justification for the authors' own work than an independent assessment of a research area. A Nature Reviews Cancer submission readiness check can assess whether a proposed article is positioned appropriately for a commissioned review journal or whether a primary-research or specialty review submission is the better path.

The acceptance rate at Nature Reviews Cancer is only one dimension of selectivity. What matters more is where in the process papers are filtered. Most rejections at selective journals happen at the desk - the editor reads the abstract, cover letter, and first few paragraphs and decides whether to send the paper for external review. Papers that make it past the desk have substantially better odds.

For authors, this means the real question is not "what percentage of papers get accepted?" but "will my paper survive the desk screen?" The desk screen is about scope fit, novelty signal, and evidence maturity - not about statistical odds.

If you are considering Nature Reviews Cancer, these specific steps improve your chances:

• Lead with the advance, not the method. The first paragraph of your abstract should state what changed in the field, not how you ran the experiment.

• Match the journal's scope precisely. Read the last 3 issues. If your paper's topic doesn't appear, the desk rejection risk is high.

• Include a cover letter that addresses fit. Name the specific reason this paper belongs at Nature Reviews Cancer rather than a competitor.

• Ensure the data package is complete. Missing controls, weak statistics, or incomplete characterization are common desk-rejection triggers.

• Check formatting requirements. Trivial formatting errors signal carelessness to editors.

For Nature Reviews Cancer, authors should expect:

These are approximate ranges. Actual timelines vary by manuscript complexity, reviewer availability, and whether revisions are needed.

The acceptance rate for Nature Reviews Cancer does not distinguish between desk rejections and post-review rejections. A paper desk-rejected in 2 weeks and a paper rejected after 4 months of review both count the same. The rate also does not reveal how acceptance varies by article type, geographic origin, or research area within the journal's scope.

Acceptance rates cannot predict your individual odds. A strong paper with clear scope fit, complete data, and solid methodology has substantially better odds than the headline number suggests. A weak paper with methodology gaps will be rejected regardless of the journal's overall rate.

A Nature Reviews Cancer submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.